2220 related articles for article (PubMed ID: 33709868)
21. Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points.
Pisani F; Rosa Pisani L; Barbieri MA; de Leon J; Spina E
Curr Neuropharmacol; 2023; 21(8):1755-1766. PubMed ID: 35619263
[TBL] [Abstract][Full Text] [Related]
22. Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE.
Ekstein D; Noyman I; Fahoum F; Herskovitz M; Linder I; Ben Zeev B; Eyal S
Isr Med Assoc J; 2020 Nov; 11(22):665-672. PubMed ID: 33249784
[TBL] [Abstract][Full Text] [Related]
23. Withdrawal seizures: possible risk factors.
Matricardi S; Operto FF; Farello G; Coppola G; Verrotti A
Expert Rev Neurother; 2020 Jul; 20(7):667-672. PubMed ID: 32515638
[TBL] [Abstract][Full Text] [Related]
24. Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population.
Maglalang PD; Wen J; Hornik CP; Gonzalez D
Clin Transl Sci; 2024 Apr; 17(4):e13793. PubMed ID: 38618871
[TBL] [Abstract][Full Text] [Related]
25. Suicidality and antiepileptic drugs in people with epilepsy: an update.
Mula M
Expert Rev Neurother; 2022 May; 22(5):405-410. PubMed ID: 35394392
[TBL] [Abstract][Full Text] [Related]
26. Cardiac adverse effects of antiseizure medications.
Zaccara G; Lattanzi S; Brigo F
Expert Opin Drug Saf; 2022 May; 21(5):641-652. PubMed ID: 34942077
[TBL] [Abstract][Full Text] [Related]
27. Movement disorders associated with antiseizure medications: A real-world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System.
Zhou J; Wei Z; Chen S; Xie H; Huang W; Liu M; Wu X
Br J Clin Pharmacol; 2023 Nov; 89(11):3389-3400. PubMed ID: 37353394
[TBL] [Abstract][Full Text] [Related]
28. Interactions between antiseizure medications and foods and drinks: A systematic review.
Asadi-Pooya AA; Johannessen Landmark C; Mirzaei Damabi N; Fazelian K
Epilepsia Open; 2024 Apr; 9(2):475-485. PubMed ID: 38345419
[TBL] [Abstract][Full Text] [Related]
29. Non-vitamin K Oral Anticoagulants and Anti-seizure Medications: A Retrospective Cohort Study.
Ho CJ; Chen SH; Lin CH; Lu YT; Hsu CW; Tsai MH
Front Neurol; 2020; 11():588053. PubMed ID: 33732201
[No Abstract] [Full Text] [Related]
30. Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.
Banach M; Popławska M; Błaszczyk B; Borowicz KK; Czuczwar SJ
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1067-80. PubMed ID: 27267259
[TBL] [Abstract][Full Text] [Related]
31. The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?
Gunasekera CL; Sirven JI; Feyissa AM
J Cent Nerv Syst Dis; 2023; 15():11795735231209209. PubMed ID: 37868934
[TBL] [Abstract][Full Text] [Related]
32. Web-based decision support system for patient-tailored selection of antiseizure medication in adolescents and adults: An external validation study.
Hadady L; Klivényi P; Perucca E; Rampp S; Fabó D; Bereczki C; Rubboli G; Asadi-Pooya AA; Sperling MR; Beniczky S
Eur J Neurol; 2022 Feb; 29(2):382-389. PubMed ID: 34741372
[TBL] [Abstract][Full Text] [Related]
33. Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications.
Asadi-Pooya AA; Patel AA; Trinka E; Mazurkiewicz-Beldzinska M; Cross JH; Welty TE
Epileptic Disord; 2022 Oct; 24(5):751-764. PubMed ID: 35894673
[TBL] [Abstract][Full Text] [Related]
34. Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy.
Fernandes M; Dono F; Dainese F; Renna R; Consoli S; Gaspari C; Izzi F; Pagliuca M; Placidi F; Biagio Mercuri N; Liguori C
Epilepsy Behav; 2021 Dec; 125():108391. PubMed ID: 34742034
[TBL] [Abstract][Full Text] [Related]
35. Interactions of antiepileptic drugs with drugs approved for the treatment of indications other than epilepsy.
Borowicz-Reutt KK; Czuczwar SJ; Rusek M
Expert Rev Clin Pharmacol; 2020 Dec; 13(12):1329-1345. PubMed ID: 33305639
[No Abstract] [Full Text] [Related]
36. Sex Differences in Adverse Effects of Antiseizure Medications in Adults with Epilepsy: A Systematic Review.
Giuliano L; Durante V; Battaglia G; Gasparini S; Zambrelli E; Ermio C; La Neve A; Mostacci B;
CNS Drugs; 2024 Jun; 38(6):409-423. PubMed ID: 38691320
[TBL] [Abstract][Full Text] [Related]
37. Adherence to Antiseizure vs Other Medications Among US Medicare Beneficiaries With and Without Epilepsy.
Terman SW; Kerr WT; Aubert CE; Hill CE; Marcum ZA; Burke JF
Neurology; 2022 Jan; 98(4):e427-e436. PubMed ID: 34893556
[TBL] [Abstract][Full Text] [Related]
38. Prescribing pattern of anti-seizure medications (ASMs): an evaluation of extent of xanthine co-medication.
Manjula D; David J; Kulkarni C
Pol J Pharmacol; 2002; 54(3):285-91. PubMed ID: 12398162
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D abnormalities and bone turn over analysis in children with epilepsy in the Western Cape of South Africa.
Kija E; Gidal BE; Shapson-Coe A; Cader S; van der Watt G; Delport S; Wilmshurst JM
Seizure; 2019 Jul; 69():186-192. PubMed ID: 31075750
[TBL] [Abstract][Full Text] [Related]
40. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Odi R; Franco V; Perucca E; Bialer M
Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
